This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mubareka, S.
Right arrow Articles by Tipples, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mubareka, S.
Right arrow Articles by Tipples, G. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
*Infections and Pregnancy
*Rubella

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2007, p. 231-233, Vol. 45, No. 1
0095-1137/07/$08.00+0     doi:10.1128/JCM.01243-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evaluation of Commercial Rubella Immunoglobulin G Avidity Assays{triangledown}

Samira Mubareka,1 Hannah Richards,2 Michael Gray,2 and Graham A. Tipples1,2*

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba,1 National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada2

Received 16 June 2006/ Returned for modification 11 August 2006/ Accepted 25 October 2006

We compared the performances of five commercial rubella virus immunoglobulin G (IgG) avidity assays. The Adaltis (kappa = 0.28) and Diesse (kappa = 0.33) assays showed poor correlation, the Behring assay (kappa = 0.68) showed good correlation, and the Euroimmun (kappa = 0.95) and Radim (kappa = 0.94) assays showed excellent correlation with a well-established in-house rubella virus IgG avidity assay. The Euroimmun and Radim assays were statistically significantly better than the other commercial assays (P < 0.01).

* Corresponding author. Mailing address: National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada, R3E 3R2. Phone: (204) 789-6080. Fax: (204) 789-7039. E-mail: Graham_Tipples{at}phac-aspc.gc.ca.

{triangledown} Published ahead of print on 8 November 2006.

Journal of Clinical Microbiology, January 2007, p. 231-233, Vol. 45, No. 1
0095-1137/07/$08.00+0     doi:10.1128/JCM.01243-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vauloup-Fellous, C., Ursulet-Diser, J., Grangeot-Keros, L. (2007). Development of a Rapid and Convenient Method for Determination of Rubella Virus-Specific Immunoglobulin G Avidity. CVI 14: 1416-1419 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»